All Stories

  1. PAI-1 and TAFI in advanced carotid plaque
  2. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: reply
  3. Characterization of thrombin derived from human recombinant prothrombin
  4. Addition of prothrombin to plasma can result in a paradoxical increase in activated partial thromboplastin time
  5. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood
  6. The effect of recombinant and plasma-derived prothrombin on prothrombin time in human plasma
  7. A serendipitously identified novel small molecule procoagulant compound giving rise to a high-throughput screening assay based on human plasma
  8. Identification of Structural–Kinetic and Structural–Thermodynamic Relationships for Thrombin Inhibitors
  9. produce ecarin in vitro instead of from the venom of the saw-scaled viper
  10. Platelets Retain High Levels of Active Plasminogen Activator Inhibitor 1
  11. Monitoring of Protein Conformational Changes Upon Interaction with Low Molecular Weight Compounds by QCM-D and its Application to Drug Discovery
  12. Viscoelastic Sensing of Conformational Changes in Plasminogen Induced upon Binding of Low Molecular Weight Compounds
  13. The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by α2-macroglobulin-thrombin
  14. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637
  15. Synthesis and biological activity of potent, low molecular weight renin inhibitors*
  16. A Novel Surface Modification Using Tissue Factor Reconstituted in Phospholipid Vesicles for the Activation of Blood Coagulation
  17. Clavatadine A, A Natural Product with Selective Recognition and Irreversible Inhibition of Factor XIa†
  18. Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin
  19. X-ray crystal structure of endothiapepsin complexed with compound 1
  20. Discovery of a Novel Warhead against β-Secretase through Fragment-Based Lead Generation§
  21. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia
  22. Probing the interaction of coagulation factors with phospholipid vesicle surfaces by surface plasma resonance
  23. Biochemical importance of glycosylation of plasminogen activator inhibitor-1
  24. Hemodynamic improvement and removal of autoantibodies against β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy
  25. The interaction between captured human thrombin and antithrombin studied by surface plasmon resonance, and the effect of melagatran
  26. A Thermodynamic Characterization of the Binding of Thrombin Inhibitors to Human Thrombin, Combining Biosensor Technology, Stopped-Flow Spectrophotometry, and Microcalorimetry
  27. Effect of Different Types of Thrombin Inhibitors on Thrombin/Thrombomodulin Modulated Activation of Protein C In Vitro
  28. Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors
  29. A Regulatory Hydrophobic Area in the Flexible Joint Region of Plasminogen Activator Inhibitor-1, Defined with Fluorescent Activity-neutralizing Ligands. LIGAND-INDUCED SERPIN POLYMERIZATION
  30. Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors
  31. Characterization of the interaction of plasminogen activator inhibitor type 1 with vitronectin by surface plasmon resonance
  32. Protein movement during complex-formation between tissue plasminogen activator and plasminogen activator inhibitor-1
  33. HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE
  34. Sideroxylonal C, a New Inhibitor of Human Plasminogen Activator Inhibitor Type-1, from the Flowers of Eucalyptus albens
  35. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide
  36. Identification of the Binding Site for a Low-Molecular-Weight Inhibitor of Plasminogen Activator Inhibitor Type 1 by Site-Directed Mutagenesis
  37. The Mechanism of Binding of Low-Molecular-Weight Active Site Inhibitors to Human α-Thrombin
  38. Comparison of chromogenic substrates for tissue plasminogen activator and the effects on the stability of plasminogen activator inhibitor type-1
  39. Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator
  40. Serpin Conformational Change in Ovalbumin. Enhanced Reactive Center Loop Insertion through Hinge Region Mutations†
  41. Detergent tween 80 modifies the specific activity of PAI-1
  42. Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography
  43. Characterisation of novel indenoindoles. Part II. Redox-recycling with ascorbate
  44. Design and synthesis of thrombin inhibitors
  45. Inhibitors of thrombin containing arginine ketone derivatives
  46. Thrombin Inhibitors as Antithrombotic Agents: The Importance of Rapid Inhibition
  47. Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator
  48. Separation of Active and Inactive Forms of Recombinant Human Plasminogen Activator Inhibitor Type 1 (PAI-1) Expressed in Chinese Hamster Ovary Cells: Comparison with Native Human PAI-1
  49. An EPR Study of the Alkylhydrazyl Radicals Formed at Room Temperature in the Photochemical Reaction of 2,2'-Azobis(2,4-dimethylvaleronitrile) or 2,2'-Azobis(propane-2-carboxamidine) Dihydrochloride in the Presence of Sensitizers.
  50. An antibody ragment against PAI-1 inhibits PAI-1 activity and stimulates fibrinolysis in vitro and in vivo
  51. The interaction of PAI-1 with immobilised vitronectin and the effect of tPA and the protease domain of tpa
  52. PAI-1 Binds exclusively to the protease domain of tPA
  53. The effect of estramustine derivatives on microtubule assembly in vitro depends on the charge of the substituent
  54. Stereochemistry of colchicinoids. Enantiomeric stability and binding to tubulin of desacetamidocolchicine and desacetamidoisocolchicine
  55. Conformation of thiocolchicine and two B-ring-modified analogs bound to tubulin studied with optical spectroscopy
  56. Small, potent and stable inhibitors of renin
  57. Cis-trans isomerization of an angiotensin I-converting enzyme inhibitor. An enzyme kinetic and nuclear magnetic resonance study
  58. Conformational differences between latent and active plasminogen activator inhibitor, PAI-1: A spectroscopic study
  59. Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases
  60. Effects of proteolysis of the extending parts of the high-molecular-weight microtubule-associated proteins on interactions between microtubules
  61. Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2
  62. Flow orientation of brain microtubules studies by linear dichroism
  63. Estramustine Phosphate Inhibits Microtubule Assembly by Binding to the Microtubule-Associated Proteins
  64. The effect of gossypol on fast axonal transport and microtubule assembly
  65. Binding to tubulin of an allocolchicine spin probe: interaction with the essential SH groups and other active sites
  66. Changes in the hydrodynamic properties of microtubules induced by taxol
  67. Diethylstilbestrol induces metaphase arrest and inhibits microtubule assembly
  68. The binding of Ruthenium red to tubulin
  69. Interaction of estramustine phosphate with microtubule-associated proteins
  70. Molecular weight dependency of heparin inhibition of microtubule assembly in vitro
  71. The effect of S-100a and S-100b proteins and Zn2+ on the assembly of brain microtubule proteins in vitro
  72. Tubulin
  73. Effect of cibacron blue on tubulin assembly in the absence and presence of microtubule-associated proteins
  74. Effect of S-100 proteins and calmodulin on Ca2+ -induced disassembly of brain microtubule proteins in vitro
  75. ChemInform Abstract: SYNTHESIS AND BINDING TO TUBULIN OF AN ALLOCOLCHICINE SPIN PROBE
  76. Iron, an Essential Component of 4-Hydroxyphenylpyruvate Dioxygenase from Pseudomonas sp. Strain P.J. 874
  77. Spatial separation of the two essential thiol groups and the binding site of the exchangeable GTP in brain tubulin
  78. The effect of ruthenium red on the assembly and disassembly of microtubules and on rapid axonal transport
  79. Synthesis and Binding to Tubulin of an Allocolchicine Spin Probe.
  80. Metal analysis by energy dispersive X-ray fluorescence of bovine brain tubulin and microtubule-associated proteins prepared by phosphocellulose chromatography
  81. The reaction of mercaptans with tyrosinases and hemocyanins
  82. The effect of pH on the oxygen intermediate and the dioxygen reducing site in blue oxidases
  83. A mass spectrometric investigation of the reaction between 18 O2 and reduced tree laccase A differentiation between the two water molecules formed
  84. Type 2 copper(II) as a component of the dioxygen reducing site in laccase: Evidence from EPR experiments with17O
  85. An EPR study of Neurospora tyrosinase
  86. A 17O-effect on the EPR spectrum of the intermediate in the dioxygen-laccase reaction
  87. A paramagnetic intermediate in the reduction of oxygen by reduced laccase
  88. 17O hyperfine interaction in the EPR spectrum of fungal laccase A
  89. Sulfhydryl groups, disulfide bridges and the state of copper in three blue oxidases
  90. The stoichiometry of the three different types of copper in ascorbate oxidase from green zucchini squash
  91. The stoichiometry of the paramagnetic copper and the oxidation-reduction potentials of type I copper in human ceruloplasmin